1. Home
  2. CHPG vs INCR Comparison

CHPG vs INCR Comparison

Compare CHPG & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHPG
  • INCR
  • Stock Information
  • Founded
  • CHPG 2024
  • INCR 1994
  • Country
  • CHPG United States
  • INCR Israel
  • Employees
  • CHPG N/A
  • INCR N/A
  • Industry
  • CHPG
  • INCR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHPG
  • INCR Health Care
  • Exchange
  • CHPG Nasdaq
  • INCR Nasdaq
  • Market Cap
  • CHPG 101.2M
  • INCR 82.3M
  • IPO Year
  • CHPG N/A
  • INCR N/A
  • Fundamental
  • Price
  • CHPG $10.14
  • INCR $1.39
  • Analyst Decision
  • CHPG
  • INCR
  • Analyst Count
  • CHPG 0
  • INCR 0
  • Target Price
  • CHPG N/A
  • INCR N/A
  • AVG Volume (30 Days)
  • CHPG 8.4K
  • INCR 37.8K
  • Earning Date
  • CHPG 07-23-2025
  • INCR 10-08-2025
  • Dividend Yield
  • CHPG N/A
  • INCR N/A
  • EPS Growth
  • CHPG N/A
  • INCR N/A
  • EPS
  • CHPG N/A
  • INCR N/A
  • Revenue
  • CHPG N/A
  • INCR $72,158,312.00
  • Revenue This Year
  • CHPG N/A
  • INCR $69.54
  • Revenue Next Year
  • CHPG N/A
  • INCR $41.75
  • P/E Ratio
  • CHPG N/A
  • INCR N/A
  • Revenue Growth
  • CHPG N/A
  • INCR N/A
  • 52 Week Low
  • CHPG $9.81
  • INCR $1.17
  • 52 Week High
  • CHPG $10.24
  • INCR $1.80
  • Technical
  • Relative Strength Index (RSI)
  • CHPG N/A
  • INCR 34.26
  • Support Level
  • CHPG N/A
  • INCR $1.42
  • Resistance Level
  • CHPG N/A
  • INCR $1.52
  • Average True Range (ATR)
  • CHPG 0.00
  • INCR 0.07
  • MACD
  • CHPG 0.00
  • INCR -0.02
  • Stochastic Oscillator
  • CHPG 0.00
  • INCR 0.00

About CHPG ChampionsGate Acquisition Corporation Class A Ordinary Share

Championsgate Acquisition Corp is a blank check company.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: